الصفحة الرئيسية>>Analytical Standards>> Reference Materials>>ALEPH-4

ALEPH-4 (Synonyms: 2,5-Dimethoxy-4-iso-propylthioamphetamine)

رقم الكتالوجGC18896

ALEPH-4 is a homolog of 2,5-dimethoxy-4-methylthioamphetamine (DOT), a substituted amphetamine of the phenethylamine class of abused compounds.

Products are for research use only. Not for human use. We do not sell to patients.

ALEPH-4 التركيب الكيميائي

Cas No.: 123643-26-5

الحجم السعر المخزون الكميّة
1mg
102٫00
متوفر
5mg
381٫00
متوفر
50mg
2023٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products
ALEPH-4 is a homolog of 2,5-dimethoxy-4-methylthioamphetamine (DOT), a substituted amphetamine of the phenethylamine class of abused compounds. It contains an isopropyl group in place of the methyl group extending from the thiol on the amphetamine base structure. This product is intended for forensic and research applications. This product is a qualified Reference Material (RM) that has been manufactured and tested to meet ISO17025 and Guide 34 guidelines. These materials are tested using validated analytical methods on qualified instrumentation to ensure traceability of measurements. All traceable RMs may be distinguished by their CofAs and can be downloaded below using the batch number located on the product label. For a representative CofA please contact our technical support.

مراجعات

Review for ALEPH-4

Average Rating: 5 ★★★★★ (Based on Reviews and 27 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for ALEPH-4

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.